Hospital de Santa Maria MHM is a public Central Hospital serving the Greater Lisbon area as part of the Northern Lisbon University Hospital Centre, a State-owned enterprise. Santa Maria is the largest hospital in Lisbon and indeed in Portugal.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at University Hospital of Santa Maria
During the past decade, University Hospital of Santa Maria conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance
2008-01-01
2008-10-01
Completed
43
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Santa Maria"
#1 collaborator was "A2F Associates Limited" with 2 trials as a collaborator, "Alpha Bioresearch S.L." with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Azienda Ospedaliera di Padova" with 2 trials as a collaborator and "Hospital Universitari Vall d'Hebron Research Institute" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at University Hospital of Santa Maria
According to Clinical.Site data, the most researched conditions in "University Hospital of Santa Maria" are
"Circulating Tumor Cell" (1 trials), "Liver Cirrhosis" (1 trials), "Non-Alcoholic Steatohepatitis" (1 trials), "Prostate Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "University Hospital of Santa Maria" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital of Santa Maria
Most popular intervention types in "University Hospital of Santa Maria" are "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "10-core prostate biopsy protocol" (1 trials), "4g Placebo" (1 trials), "4g Yaq-001" (1 trials), "8g Placebo" (1 trials) and "8g Yaq-001" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital of Santa Maria
The vast majority of trials in "University Hospital of Santa Maria" are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at University Hospital of Santa Maria
Currently, there are NaN active trials in "University Hospital of Santa Maria".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University Hospital of Santa Maria,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital of Santa Maria, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".